ATRA Financial Statements

Balance sheet, income statement, cash flow, and dividends for Atara Biotherapeutics Inc (ATRA).


$76.66M Market Cap.

As of 03/07/2025 5:00 PM ET (MRY) • Disclaimer

ATRA Market Cap. (MRY)


ATRA Shares Outstanding (MRY)


ATRA Assets (MRY)


Total Assets

$109.10M

Total Liabilities

$206.38M

Total Investments

$17.47M

ATRA Income (MRY)


Revenue

$128.94M

Net Income

-$85.40M

Operating Expense

$191.37M

ATRA Cash Flow (MRY)


CF Operations

-$68.72M

CF Investing

$8.62M

CF Financing

$59.28M

ATRA Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ATRA Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$109,098,000 (-34.08%)

$165,504,000 (-56.03%)

$376,420,000 (-19.59%)

$468,127,000 (-20.40%)

Assets Current

$64,894,000 (-36.30%)

$101,869,000 (-65.48%)

$295,080,000 (-23.28%)

$384,621,000 (-26.50%)

Assets Non-Current

$44,204,000 (-30.54%)

$63,635,000 (-21.77%)

$81,340,000 (-2.59%)

$83,506,000 (28.77%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

-$97,283,000 (1.96%)

-$99,231,000 (-178.36%)

$126,640,000 (-54.71%)

$279,614,000 (-39.52%)

Property Plant & Equipment Net

$41,101,000 (-30.09%)

$58,791,000 (-20.90%)

$74,322,000 (-7.03%)

$79,939,000 (27.25%)

Cash & Equivalents

$25,176,000 (-3.12%)

$25,987,000 (-72.08%)

$93,088,000 (-12.41%)

$106,278,000 (-47.02%)

Accumulated Other Comprehensive Income

$8,000 (103.92%)

-$204,000 (90.13%)

-$2,067,000 (-461.68%)

-$368,000 (-224.32%)

Deferred Revenue

$95,092,000 (-17.59%)

$115,395,000 (35.76%)

$85,000,000 (-11.89%)

$96,468,000 (57.50%)

Total Investments

$17,466,000 (-32.52%)

$25,884,000 (-82.73%)

$149,877,000 (-43.69%)

$266,184,000 (-11.70%)

Investments Current

$17,466,000 (-32.52%)

$25,884,000 (-82.73%)

$149,877,000 (-43.44%)

$264,984,000 (-11.75%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$1,200,000 (0.00%)

Inventory

$10,655,000 (9.78%)

$9,706,000 (511.98%)

$1,586,000 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$1,482,000 (-95.65%)

$34,108,000 (-15.20%)

$40,221,000 (3979.21%)

$986,000 (-21.12%)

Trade & Non-Trade Payables

$4,367,000 (18.54%)

$3,684,000 (-46.38%)

$6,871,000 (-60.44%)

$17,368,000 (144.00%)

Accumulated Retained Earnings (Deficit)

-$2,054,553,000 (-4.34%)

-$1,969,150,000 (-16.31%)

-$1,693,024,000 (-15.59%)

-$1,464,722,000 (-30.25%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$68,538,000 (-14.66%)

$80,316,000 (-9.04%)

$88,300,000 (246.03%)

$25,518,000 (95.68%)

Debt Current

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Debt Non-Current

$68,538,000 (-14.66%)

$80,316,000 (-9.04%)

$88,300,000 (246.03%)

$25,518,000 (95.68%)

Total Liabilities

$206,381,000 (-22.04%)

$264,735,000 (5.99%)

$249,780,000 (32.50%)

$188,513,000 (49.87%)

Liabilities Current

$134,574,000 (-5.38%)

$142,226,000 (80.22%)

$78,916,000 (-25.40%)

$105,786,000 (27.61%)

Liabilities Non-Current

$71,807,000 (-41.39%)

$122,509,000 (-28.30%)

$170,864,000 (106.54%)

$82,727,000 (92.93%)

ATRA Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$128,940,000 (1404.02%)

$8,573,000 (-86.51%)

$63,573,000 (212.55%)

$20,340,000 (0%)

Cost of Revenue

$21,009,000 (136.43%)

$8,886,000 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$39,886,000 (-21.65%)

$50,908,000 (-28.85%)

$71,553,000 (-9.20%)

$78,801,000 (22.36%)

Research & Development Expense

$151,483,000 (-32.61%)

$224,785,000 (-17.52%)

$272,533,000 (-3.36%)

$282,001,000 (15.27%)

Operating Expenses

$191,369,000 (-30.59%)

$275,693,000 (-19.88%)

$344,086,000 (-4.63%)

$360,802,000 (16.74%)

Interest Expense

$4,615,000 (-12.68%)

$5,285,000 (366.11%)

-$1,986,000 (-441.14%)

-$367,000 (85.00%)

Income Tax Expense

-$12,000 (-180.00%)

$15,000 (25.00%)

$12,000 (-73.91%)

$46,000 (206.67%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$85,403,000 (69.07%)

-$276,126,000 (-20.95%)

-$228,302,000 (32.88%)

-$340,141,000 (-10.93%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$85,403,000 (69.07%)

-$276,126,000 (-20.95%)

-$228,302,000 (32.88%)

-$340,141,000 (-10.93%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$85,403,000 (69.07%)

-$276,126,000 (-20.95%)

-$228,302,000 (32.88%)

-$340,141,000 (-10.93%)

Weighted Average Shares

$7,488,000 (-92.93%)

$105,912,000 (3.85%)

$101,990,000 (8.88%)

$93,670,000 (26.63%)

Weighted Average Shares Diluted

$7,488,000 (-92.93%)

$105,912,000 (3.85%)

$101,990,000 (8.88%)

$93,670,000 (26.63%)

Earning Before Interest & Taxes (EBIT)

-$80,800,000 (70.17%)

-$270,826,000 (-17.61%)

-$230,276,000 (32.36%)

-$340,462,000 (-10.16%)

Gross Profit

$107,931,000 (34582.75%)

-$313,000 (-100.49%)

$63,573,000 (212.55%)

$20,340,000 (0%)

Operating Income

-$83,438,000 (69.77%)

-$276,006,000 (1.61%)

-$280,513,000 (17.61%)

-$340,462,000 (-10.16%)

ATRA Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

$8,624,000 (-93.04%)

$123,866,000 (-38.97%)

$202,956,000 (811.83%)

$22,258,000 (118.44%)

Net Cash Flow from Financing

$59,282,000 (2849.35%)

$2,010,000 (-96.21%)

$53,084,000 (-48.93%)

$103,944,000 (-75.69%)

Net Cash Flow from Operations

-$68,717,000 (64.39%)

-$192,977,000 (28.64%)

-$270,430,000 (-22.63%)

-$220,522,000 (-22.00%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$811,000 (98.79%)

-$67,101,000 (-366.30%)

-$14,390,000 (84.74%)

-$94,320,000 (-174.81%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

$8,870,000 (-92.91%)

$125,064,000 (11.28%)

$112,384,000 (242.24%)

$32,838,000 (128.26%)

Capital Expenditure

-$246,000 (79.47%)

-$1,198,000 (-101.32%)

$90,572,000 (956.07%)

-$10,580,000 (-134.43%)

Issuance (Repayment) of Debt Securities

-$892,000 (5.81%)

-$947,000 (-103.15%)

$30,087,000 (11945.28%)

-$254,000 (34.70%)

Issuance (Purchase) of Equity Shares

$59,951,000 (2706.69%)

$2,136,000 (-90.24%)

$21,891,000 (-77.82%)

$98,697,000 (-76.67%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$27,001,000 (-40.51%)

$45,386,000 (-15.70%)

$53,838,000 (-0.05%)

$53,865,000 (4.90%)

Depreciation Amortization & Accretion

$17,177,000 (3.33%)

$16,624,000 (14.11%)

$14,568,000 (29.00%)

$11,293,000 (15.36%)

ATRA Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

83.70% (2362.16%)

-3.70% (-103.70%)

100.00% (0.00%)

100.00%

Profit Margin

-66.20% (97.94%)

-3220.90% (-796.94%)

-359.10% (78.53%)

-1672.30%

EBITDA Margin

-49.30% (98.34%)

-2965.10% (-773.89%)

-339.30% (79.03%)

-1618.30%

Return on Average Equity (ROAE)

86.00% (-93.95%)

1422.30% (1338.94%)

-114.80% (-11.46%)

-103.00% (-21.75%)

Return on Average Assets (ROAA)

-63.90% (47.75%)

-122.30% (-111.23%)

-57.90% (18.91%)

-71.40% (-0.14%)

Return on Sales (ROS)

-62.70% (98.02%)

-3159.10% (-772.20%)

-362.20% (78.36%)

-1673.90%

Return on Invested Capital (ROIC)

-457.30% (-189.25%)

-158.10% (-98.62%)

-79.60% (34.59%)

-121.70% (-16.57%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.17 (-495.41%)

-0.2 (86.61%)

-1.46 (66.28%)

-4.34 (8.20%)

Price to Sales Ratio (P/S)

0.77 (-87.80%)

6.33 (20.39%)

5.26 (-92.75%)

72.58

Price to Book Ratio (P/B)

-0.79 (-49.53%)

-0.53 (-121.45%)

2.46 (-50.70%)

4.98 (51.03%)

Debt to Equity Ratio (D/E)

-2.12 (20.50%)

-2.67 (-235.29%)

1.97 (192.58%)

0.67 (147.79%)

Earnings Per Share (EPS)

-11.41 (-337.16%)

-2.61 (-16.52%)

-2.24 (38.29%)

-3.63 (12.53%)

Sales Per Share (SPS)

17.22 (21159.26%)

0.08 (-87.00%)

0.62 (187.10%)

0.22 (0%)

Free Cash Flow Per Share (FCFPS)

-9.21 (-402.45%)

-1.83 (-3.97%)

-1.76 (28.54%)

-2.47 (1.52%)

Book Value Per Share (BVPS)

-12.99 (-1286.55%)

-0.94 (-175.44%)

1.24 (-58.39%)

2.98 (-52.24%)

Tangible Assets Book Value Per Share (TABVPS)

14.57 (832.18%)

1.56 (-57.65%)

3.69 (-26.15%)

5 (-37.13%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0%)

0 (0%)

-1 (75.00%)

-4 (20.00%)

Enterprise Value Over EBITDA (EV/EBITDA)

-1.62 (-494.49%)

-0.27 (80.82%)

-1.42 (64.22%)

-3.96 (19.65%)

Asset Turnover

0.96 (2439.47%)

0.04 (-76.40%)

0.16 (274.42%)

0.04 (0%)

Current Ratio

0.48 (-32.68%)

0.72 (-80.85%)

3.74 (2.83%)

3.64 (-42.40%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$68,963,000 (64.48%)

-$194,175,000 (-7.96%)

-$179,858,000 (22.17%)

-$231,102,000 (-24.74%)

Enterprise Value (EV)

$102,890,272 (48.92%)

$69,088,730 (-77.41%)

$305,814,038 (-76.56%)

$1,304,629,003 (-11.60%)

Earnings Before Tax (EBT)

-$85,415,000 (69.06%)

-$276,111,000 (-20.95%)

-$228,290,000 (32.87%)

-$340,095,000 (-10.92%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$63,623,000 (74.97%)

-$254,202,000 (-17.85%)

-$215,708,000 (34.47%)

-$329,169,000 (-9.99%)

Invested Capital

$17,886,000 (-76.95%)

$77,607,000 (-73.49%)

$292,716,000 (3.95%)

$281,581,000 (-11.36%)

Working Capital

-$69,680,000 (-72.66%)

-$40,357,000 (-118.67%)

$216,164,000 (-22.48%)

$278,835,000 (-36.68%)

Tangible Asset Value

$109,098,000 (-34.08%)

$165,504,000 (-56.03%)

$376,420,000 (-19.59%)

$468,127,000 (-20.40%)

Market Capitalization

$76,662,272 (46.68%)

$52,265,730 (-83.21%)

$311,202,038 (-77.67%)

$1,393,458,003 (-8.66%)

Average Equity

-$99,249,500 (-411.23%)

-$19,413,750 (-109.76%)

$198,887,000 (-39.75%)

$330,082,500 (-8.96%)

Average Assets

$133,590,000 (-40.81%)

$225,703,500 (-42.79%)

$394,534,250 (-17.14%)

$476,119,500 (10.64%)

Invested Capital Average

$17,667,000 (-89.69%)

$171,291,500 (-40.79%)

$289,288,500 (3.38%)

$279,834,750 (-5.46%)

Shares

5,759,750 (-94.35%)

101,922,250 (7.42%)

94,878,670 (7.31%)

88,417,386 (13.77%)